Patent details

Basic Information

Publication number:

EP2332915

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP081715237

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Beta2-adrenoceptor agonists

French Title of Invention:

Agonistes du beta-2-adrenorecepteur

German Title of Invention:

Beta2-Adrenoceptor Agonisten

SPC Number:

Dates

Filing date:

02/06/2000

Grant date:

27/02/2013

EP Publication Date:

27/02/2013

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/06/2011

EP B1 Publication Date:

27/02/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

02/06/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

02/06/2000

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:

Novartis Pharma GmbH

Address:

Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:

Bruce Ian

Address:

United Kingdom (GB)

2

Name:

Beattie David

Address:

United Kingdom (GB)

3

Name:

Fairhurst Robin Alec

Address:

United Kingdom (GB)

4

Name:

Cuenoud Bernard

Address:

Switzerland (CH)

Priority

Priority Number:

9913083

Priority Date:

04/06/1999

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

C07D 215/26;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

24/05/2019

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages